Legend Biotech (LEGN) Net Income (QoQ) (2019 - 2025)
Legend Biotech (LEGN) Net Income (QoQ) (2019 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - |
| 10 | Legend Biotech | 8.26 Bn | 7.36 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 19.65% |
| Sep 30, 2025 | 69.04% |
| Jun 30, 2025 | -27.61% |
| Mar 31, 2025 | -470.35% |
| Dec 31, 2024 | 122.57% |
| Sep 30, 2024 | -556.28% |
| Jun 30, 2024 | 70.32% |
| Mar 31, 2024 | 58.72% |
| Dec 31, 2023 | -130.66% |
| Sep 30, 2023 | 68.38% |
| Jun 30, 2023 | -77.52% |
| Mar 31, 2023 | 17.69% |
| Dec 31, 2022 | -60.22% |
| Sep 30, 2022 | 56.04% |
| Jun 30, 2022 | -503.55% |
| Mar 31, 2022 | 62.27% |
| Dec 31, 2021 | 32.09% |
| Sep 30, 2021 | 27.63% |
| Jun 30, 2021 | -174,579.35% |
| Mar 31, 2021 | 99.83% |